Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Shigeki Takemoto"'
Autor:
Asahi Ito, Yui Suzuki, Ayako Masaki, Shinichiro Yoshida, Hitoshi Suzushima, Shigeki Takemoto, Atae Utsunomiya, Toshihiko Ishii, Masanori Hiura, Takeshi Takahashi, Satoshi Yurimoto, Hiroshi Inagaki, Akimichi Morita, Shinsuke Iida, Takashi Ishida
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 2, Iss 4, Pp 102-107 (2019)
Abstract Purpose Skin disorders demonstrate highly variable phenotypical and histopathological features. Mogamulizumab, a humanized anti‐CC chemokine receptor 4 monoclonal antibody indicated for the treatment of adult T‐cell leukemia‐lymphoma,
Externí odkaz:
https://doaj.org/article/1b8fc13cc8ab42f4ad0fd3df134da49b
Autor:
Shingo Nakahata, Chilmi Syahrul, Ayako Nakatake, Kuniyo Sakamoto, Maki Yoshihama, Ichiro Nishikata, Yoshinori Ukai, Tadashi Matsuura, Takuro Kameda, Kotaro Shide, Yoko Kubuki, Tomonori Hidaka, Akira Kitanaka, Akihiko Ito, Shigeki Takemoto, Nobuaki Nakano, Masumichi Saito, Masako Iwanaga, Yasuko Sagara, Kosuke Mochida, Masahiro Amano, Kouichi Maeda, Eisaburo Sueoka, Akihiko Okayama, Atae Utsunomiya, Kazuya Shimoda, Toshiki Watanabe, Kazuhiro Morishita
Publikováno v:
Haematologica, Vol 106, Iss 2 (2020)
Adult T-cell leukemia/leukemia (ATLL) is an aggressive peripheral T-cell malignancy, caused by infection with the human T-cell leukemia virus type 1 (HTLV-1). We have recently shown that cell adhesion molecule 1 (CADM1), a member of the immunoglobuli
Externí odkaz:
https://doaj.org/article/b03871741242448c8f07b8ce170b7626
Autor:
Ichiro Nishikata, Maki Yoshihama, Kotaro Shide, Yoko Kubuki, Kuniyo Sakamoto, Yasuko Sagara, Nobuaki Nakano, Shigeki Takemoto, Toshiki Watanabe, Masahiro Amano, Atae Utsunomiya, Masumichi Saito, Akihiko Okayama, Tadashi Matsuura, Kouichi Maeda, Kosuke Mochida, Shingo Nakahata, Eisaburo Sueoka, Kazuhiro Morishita, Tomonori Hidaka, Masako Iwanaga, Kazuya Shimoda, Takuro Kameda, Yoshinori Ukai, Akira Kitanaka, Ayako Nakatake, Akihiko Ito, Chilmi Syahrul
Publikováno v:
Haematologica
Adult T-cell leukemia/leukemia (ATLL) is an aggressive peripheral T-cell malignancy, caused by infection with the human T-cell leukemia virus type 1 (HTLV-1). We have recently shown that cell adhesion molecule 1 (CADM1), a member of the immunoglobuli
Autor:
Naoya Taira, Kensei Tobinai, Yoshio Saburi, Atae Utsunomiya, Ilseung Choi, Hiroshi Fujiwara, Kenji Ishitsuka, Yukiyoshi Moriuchi, Ryuzo Ueda, Takashi Ishida, Tatsuro Jo, Yukio Kobayashi, Youko Suehiro, Kazunori Imada, Shinichiro Yoshida, Kisato Nosaka, Shigeki Takemoto, Hitoshi Suzushima, Makoto Yoshimitsu, Kenichi Yoshimura, Kazuhito Yamamoto, Takeshi Takahashi, Koji Kato
Publikováno v:
British Journal of Haematology. 184:479-483
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 16:8253-8258
Elevated levels of soluble CD30 (sCD30) are linked with various T-cell neoplasms. However, the relationship between sCD30 levels and the development of adult T-cell leukemia (ATL) in human T-cell leukemia virus type 1 (HTLV-1) carriers remains to be
Autor:
Naoya Taira, Ryuzo Ueda, Tatsuro Jo, Kazunori Imada, Masao Tomonaga, Kenji Ishitsuka, Yukiyoshi Moriuchi, Toshihiro Miyamoto, Hitoshi Suzushima, Kazuhito Yamamoto, Kisato Nosaka, Shiro Akinaga, Naokuni Uike, Kimiharu Uozumi, Atae Utsunomiya, Hiroshi Fujiwara, Takashi Ishida, Shigeki Takemoto, Kensei Tobinai, Yoshio Saburi, Shinichiro Yoshida
Publikováno v:
British Journal of Haematology
This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4 antibody, to mLSG15, a dose‐intensified chemotherapy, further increases efficacy without comprom
Autor:
Shinichiro Yoshida, Takeshi Takahashi, Kazuhito Yamamoto, Yoshitaka Imaizumi, Takashi Ishida, Yukio Kobayashi, Kouichi Kawamura, Kensei Tobinai, Tatsuro Jo, Kenichi Yoshimura, Shigeki Takemoto, Hitoshi Suzushima, Atae Utsunomiya, Ryuzo Ueda, Koji Kato
Publikováno v:
Cancer Science
The present study sought to elucidate the prognosis of adult T-cell leukemia-lymphoma (ATL) patients receiving mogamulizumab, a defucosylated anti-CCR4 monoclonal antibody. Progression-free survival (PFS) and overall survival (OS) of ATL patients enr
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 57(7)
Adult T-cell leukemia (ATL) is an aggressive neoplasm of mature T cells. We aimed to ascertain the relationships between soluble CD25 (sIL-2R) and CD30 (sCD30) levels and nodal or extra-nodal involvement of ATL. Our study subjects were ATL patients w
Autor:
Kenji Ishitsuka, Takashi Ishida, Yoshio Saburi, Kunihiro Tsukasaki, Kisato Nosaka, Atae Utsunomiya, Shinichiro Yoshida, Kazuhito Yamamoto, Kensei Tobinai, Shiro Akinaga, Tatsuro Joh, Michinori Ogura, Ryuzo Ueda, Hiroshi Inagaki, Hiroshi Fujiwara, Shigeki Takemoto, Masao Tomonaga, Naokuni Uike, Toshihiro Miyamoto, Hitoshi Suzushima
Publikováno v:
Journal of Clinical Oncology. 30:837-842
Purpose Adult T-cell leukemia-lymphoma (ATL) is usually resistant to conventional chemotherapies, and there are few other treatment options. Because CC chemokine receptor 4 (CCR4) is expressed on tumor cells from most patients with ATL, KW-0761, a hu
Autor:
Yoshiko Inoue, T. Sakai, S Iwasaki, M Takahashi, Fumio Kawano, S Onishi, Toshiro Kawakita, Noboru Harada, Shigeki Takemoto, Shoichi Nagakura, T. Kiyokawa, Michihiro Hidaka, Toshiji Saibara, Takahiro Matsui
Publikováno v:
Bone Marrow Transplantation. 45:912-918
Chronic GVHD (cGVHD) of the liver is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-SCT). It is characterized by the destruction of bile duct epithelium followed by progressive cholestasis